Frontiers in Oncology (Jun 2021)

Longitudinal Genomic Evolution of Conventional Papillary Thyroid Cancer With Brain Metastasis

  • Han Luo,
  • Xue Liao,
  • Yun Qin,
  • Qianqian Hou,
  • Zhinan Xue,
  • Yang Liu,
  • Yang Liu,
  • Feiyang Shen,
  • Yuelan Wang,
  • Yong Jiang,
  • Linlin Song,
  • Linlin Song,
  • Haining Chen,
  • Lingyun Zhang,
  • Lingyun Zhang,
  • Tao Wei,
  • Lunzhi Dai,
  • Li Yang,
  • Wei Zhang,
  • Zhihui Li,
  • Heng Xu,
  • Heng Xu,
  • Jingqiang Zhu,
  • Yang Shu,
  • Yang Shu

DOI
https://doi.org/10.3389/fonc.2021.620924
Journal volume & issue
Vol. 11

Abstract

Read online

BackgroundBrain metastasis is extremely rare but predicts dismal prognosis in papillary thyroid cancer (PTC). Dynamic evaluation of stepwise metastatic lesions was barely conducted to identify the longitudinal genomic evolution of brain metastasis in PTC.MethodChronologically resected specimen was analyzed by whole exome sequencing, including four metastatic lymph nodes (lyn 1–4) and brain metastasis lesion (BM). Phylogenetic tree was reconstructed to infer the metastatic pattern and the potential functional mutations.ResultsContrasting with lyn1, ipsilateral metastatic lesions (lyn2–4 and BM) with shared biallelic mutations of TSC2 indicated different genetic originations from multifocal tumors. Lyn 3/4, particularly lyn4 exhibited high genetic similarity with BM. Besides the similar mutational compositions and signatures, shared functional mutations (CDK4R24C, TP53R342*) were observed in lyn3/4 and BM. Frequencies of these mutations gradually increase along with the metastasis progression. Consistently, TP53 knockout and CDK4R24C introduction in PTC cells significantly decreased radioiodine uptake and increased metastatic ability.ConclusionGenomic mutations in CDK4 and TP53 during the tumor evolution may contribute to the lymph node and brain metastasis of PTC.

Keywords